IBDEI1QO ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29117,1,3,0)
 ;;=3^Preventive Med,New > 64
 ;;^UTILITY(U,$J,358.3,29118,0)
 ;;=90471^^134^1355^1^^^^1
 ;;^UTILITY(U,$J,358.3,29118,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29118,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,29118,1,3,0)
 ;;=3^Immunization Admin (use w/ Vaccs)
 ;;^UTILITY(U,$J,358.3,29119,0)
 ;;=90472^^134^1355^2^^^^1
 ;;^UTILITY(U,$J,358.3,29119,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29119,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,29119,1,3,0)
 ;;=3^Immunization Admin,Ea Addl Vacc
 ;;^UTILITY(U,$J,358.3,29120,0)
 ;;=B18.2^^135^1356^26
 ;;^UTILITY(U,$J,358.3,29120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29120,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,29120,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,29120,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,29121,0)
 ;;=C44.99^^135^1356^50
 ;;^UTILITY(U,$J,358.3,29121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29121,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,29121,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,29121,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,29122,0)
 ;;=E11.9^^135^1356^15
 ;;^UTILITY(U,$J,358.3,29122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29122,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,29122,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,29122,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,29123,0)
 ;;=E11.40^^135^1356^16
 ;;^UTILITY(U,$J,358.3,29123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29123,1,3,0)
 ;;=3^Diabetes Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,29123,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,29123,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,29124,0)
 ;;=E78.2^^135^1356^27
 ;;^UTILITY(U,$J,358.3,29124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29124,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,29124,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,29124,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,29125,0)
 ;;=E78.5^^135^1356^28
 ;;^UTILITY(U,$J,358.3,29125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29125,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,29125,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,29125,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,29126,0)
 ;;=E66.3^^135^1356^44
 ;;^UTILITY(U,$J,358.3,29126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29126,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,29126,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,29126,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,29127,0)
 ;;=D64.9^^135^1356^3
 ;;^UTILITY(U,$J,358.3,29127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29127,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,29127,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,29127,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,29128,0)
 ;;=F17.200^^135^1356^41
 ;;^UTILITY(U,$J,358.3,29128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29128,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,29128,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,29128,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,29129,0)
 ;;=F17.229^^135^1356^38
 ;;^UTILITY(U,$J,358.3,29129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29129,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco
 ;;^UTILITY(U,$J,358.3,29129,1,4,0)
 ;;=4^F17.229
 ;;^UTILITY(U,$J,358.3,29129,2)
 ;;=^5003374
 ;;^UTILITY(U,$J,358.3,29130,0)
 ;;=F19.10^^135^1356^53
 ;;^UTILITY(U,$J,358.3,29130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29130,1,3,0)
 ;;=3^Substance Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,29130,1,4,0)
 ;;=4^F19.10
 ;;^UTILITY(U,$J,358.3,29130,2)
 ;;=^5003416
 ;;^UTILITY(U,$J,358.3,29131,0)
 ;;=F15.10^^135^1356^52
 ;;^UTILITY(U,$J,358.3,29131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29131,1,3,0)
 ;;=3^Stimulant Abuse,Unspec
